Dale Fisher

Last updated
Dale Fisher
Dale Fisher.jpg
Born
Dale Andrew Fisher

1960 (age 6364)
Melbourne, Australia
Education
Medical career
Field
Institutions
Website www.nuh.com.sg/patients-visitors/Pages/find-a-doctor-details.aspx?docid=Dale_Fisher

Dale Andrew Fisher FRACP (born 1960) is an infectious diseases physician who specialises in Infectious Diseases and a Senior Consultant in the Division of Infectious Diseases at the National University Hospital, Singapore. [1] He is also a professor of medicine at the Yong Loo Lin School of Medicine, National University of Singapore (2004 -), and the chair of the National Infection Prevention and Control Committee through the Ministry of Health, Singapore (2013 -). [2] In 2020, he became group chief of Medicine for National University Health Systems.

Contents

Fisher first practiced medicine in Singapore in 2003, and soon afterwards relocated permanently from Darwin, Australia. He has written numerous peer-reviewed articles in medical journals, publishingon various diseases, including melioidosis, Outpatient Parenteral Antibiotic Therapy (OPAT), Severe Acute Respiratory Disease (SARS), infection control in hospital settings especially as it relates to multi-drug-resistant pathogens and most recently COVID-19. [3]

In addition, he is involved in numerous international medical committees and groups dealing with infectious diseases and outbreak response. He has had many leadership roles in international outbreak missions and outbreak response training across Africa and Asia and worked on many Guideline Development Groups at WHO. He was chair of the steering committee of WHO’s Global Outbreak Alert & Response Network (2018-2022) [4] and was one of 12 international technical experts on the WHO mission to China in February 2020 to investigate the COVID-19 outbreak. In 2022, he was given a certificate for outstanding leadership by the Director General of WHO.

Early life and education

Fisher was born in Melbourne in 1960 but moved to Hobart, Tasmania in 1973 when his father (1926-2013) Alfred Leopold, known as Ron, was appointed the Registrar of Motor Vehicles. His mother (1929-) was a nurse who worked shifts, in order to bring in a second income throughout Fisher's schooling years.

In 1976, he attended United World College of South East Asia in Singapore [5] under an Australian government scholarship.

Fisher received his Bachelor of Medicine and Bachelor of Surgery (MBBS) degree from the University of Tasmania in 1985 and became a Fellow of the Royal Australasian College of Physicians (FRACP) in 1992, doing most of his training at the Royal Prince Alfred Hospital, Sydney. His final year of training was in Darwin under the supervision of Professor Bart Currie.

He moved to Singapore in 2003, after working more than a decade at the Royal Darwin Hospital in infectious diseases and general internal medicine.

Career and research

Fisher began his career as a Staff Specialist Physician at the Royal Darwin Hospital (RDH) in 1993 specialising in Infectious Diseases, before progressing to become the Director of Division of Medicine. He came to Singapore in 2003, after responding to a call to assist with the SARS epidemic in Singapore. In 2006, he was appointed Clinical Director of Medicine at the National University Hospital, Singapore, where he maintained his strong commitment to general medicine as a clinician and a teacher, despite his work and experience as an infectious disease physician.

In addition to his career in hospitals, Fisher is actively involved in the international medical community. He began his involvement in the Global Outbreak Alert and Response Network (GOARN) in 2009 as a training faculty in Laos, and has undertaken numerous operational and training missions as well as consultations in many countries through GOARN as well as bilateral arrangements.

In response to H1N1 2009 outbreaks, he undertook missions as requested at the national level deploying to Malaysia, Mongolia, China and Myanmar. Likewise at the request of WHO and the Liberian Government he undertook missions for the Ebola response through 2014-5 which lead to a number of published reviews and commentaries relating to clinical care and infection prevention and control. He has participated in several WHO Guidelines Development Groups in infection control, including related to Ebola, measles and COVID-19.

In February 2020, Fisher was on the World Health Organization-led team that visited China to understand technical aspects of the COVID-19 virus; the severity, transmissibility and interventions that could guide the global response to the pandemic outbreak.

He has published over 200 peer-reviewed papers in the medical literature and given almost 200 plenary and invited presentations to scientific audiences.

Fisher was also the infectious disease physician who attended to comedian Jerry Lewis, when the late comedian was admitted to hospital for meningitis while on tour in Darwin. [6] Lewis, when interviewed by Larry King, said "God must have put him in 'the bush' (aka Darwin) because Dr Fisher was the world's best infectious disease physician." [7]

Bali Bombings - 2002

The 2002 Bali bombings, which occurred on 12 October 2002 resulted in the death of 202 people and injuring many more. As the local hospital was ill-equipped to deal with the scale of disaster, many of the injured were evacuated to Darwin.

Following the bombing, Fisher wrote an article titled "The Bali bombings of 12 October 2002: lessons in disaster management for physicians", which was published in 2003. Fisher's team highlighted that hospital-based physicians should see themselves as a sizeable and flexible group with the ability to contribute in a variety of ways during a disaster. [8]

The team noted that physicians could be deployed for alternate purposes outside of hospital, such as triage and hospital liaison, and should play a central role in the overall management of inpatient care. Such arrangements could free up surgeons, enabling them to provide immediate surgical care for the wounded.

It was also opined that the incident left a great impact on the hospital, where the medical team, together with the nurses, patient-care providers, as well as the greater medical community managed an extraordinary undertaking, by handling what was considered the biggest post-war disaster to be ever met by Australian hospitals.

This event would later be identified as significant in determining Fisher's career pathway in outbreak response.

SARS - 2003

Reunion of Singapore medical staff (from left: Fisher, Paul Tambyah) on the 10th Anniversary of the SARS outbreak in Singapore SARS Reunion.jpg
Reunion of Singapore medical staff (from left: Fisher, Paul Tambyah) on the 10th Anniversary of the SARS outbreak in Singapore

During the SARS pandemic in 2003 in Singapore, Fisher with colleagues published several articles related to "Lessons from Singapore". In these articles, it was described that SARS had demonstrated a remarkable efficiency in transmission within hospitals. In fact, 76% of SARS cases in Singapore were acquired in hospitals. They also looked at the circumstances that caused transmission within hospitals, despite the use of personal protective equipment (PPE). [9]

The outbreak in hospitals resulted in dramatic changes in triage and infection-control policies. [10]

In a separate article titled "Atypical presentations of SARS" published in The Lancet , Fisher and colleagues examined the difficulties of managing SARS cases without a diagnostic test. [11] This letter described how the World Health Organization's criteria for probable or suspected SARS case had been misinterpreted. They were intended for epidemiological purposes but instead were used for triage for which they were not adequately sensitive.

Methicillin resistant Staphylococcus aureus - 2008

Methicillin-Resistant Staphylococcus aureus (MRSA) Ingestion by a Neutrophil (8423852305).jpg

In dealing with the high prevalence of methicillin-resistant Staphylococcus aureus (MRSA) within hospitals in Singapore, Fisher has participated and lead many regional and national level workgroups and committees and was key in the national rollout of universal active surveillance for acute hospital admissions.

In the article titled "Methicillin-resistant Staphylococcus aureus Control in Singapore– Moving Forward", he described how MRSA infection in hospitals could be prevented and should not be considered as an accepted tolerable by-product of healthcare. Failure to implement long-term sustainable infection control initiatives is not an option. It was also concluded that the control of MRSA in Singapore could be achieved, but it required implementation of many varied control measures across health services, and possibly would take a decade to do so. [12]

Among many other papers on MRSA, in 2013 he published "Sustained MRSA control in a hyper-endemic tertiary acute care hospital with infrastructure challenges in Singapore". It highlighted falls in bacteraemia, all clinical specimens as well as acquisition rates as a result of the previously described interventions. [13]

For their efforts in reducing the rate of MRSA superbug infection from 1 in 10 patients to 1 in 40, Fisher and his colleagues were awarded the National Clinical Excellence Team Award in 2013 by the Ministry of Health, Singapore. [14]

COVID-19

Dale Fisher with WHO Director-General Tedros Adhanom Prof Dale Fisher with WHO Director-General Tedros Adhanom.jpg
Dale Fisher with WHO Director-General Tedros Adhanom

During the ongoing COVID-19 pandemic, which began in Wuhan, China, Fisher was part of the WHO delegation that visited China to investigate technical aspects of transmission, severity and interventions preventing spread of the emerging virus. The subsequent report outlined how the world could respond to the outbreak, but warned that the world was not prepared "in capacity or mindset". [15]

He is also involved in many pilot projects that spearhead on research and response. In his article "Q&A: The novel coronavirus outbreak causing COVID-19", Fisher shared his concerns about the emerging virus. For instance, the world's population is completely vulnerable to the novel virus as it is newly emerged in humans, and the current aim of the response muts be to flatten the epidemic curve, by interrupting chains of transmission wherever possible. It was also mentioned that while there were deaths linked to the virus, the greatest concern is the overwhelming of a health system in the wake of excessive transmission. [16]

Fisher is now well known to the media for commentary regarding COVID-19 offered through television, radio, print and social media in dozens of countries of every continent and outlets including CNN, [17] CNBC, [18] BBC, [19] ABC Australia, et cetera. In addition he undertook many webinars and other virtual speaking engagements. His philosophy was that COVID-19 can and must be contained. [20] The key outbreak pillars of case management epidemiology, logistics and risk communication/community engagement are critical at all levels. Isolation of cases that are confirmed early by testing is particularly important in this outbreak. [18]

As in some ways the public face of the response in Singapore, Fisher has featured in a comic series "The COVID Chronicles". [21]


Related Research Articles

<i>Staphylococcus aureus</i> Species of Gram-positive bacterium

Staphylococcus aureus is a Gram-positive spherically shaped bacterium, a member of the Bacillota, and is a usual member of the microbiota of the body, frequently found in the upper respiratory tract and on the skin. It is often positive for catalase and nitrate reduction and is a facultative anaerobe that can grow without the need for oxygen. Although S. aureus usually acts as a commensal of the human microbiota, it can also become an opportunistic pathogen, being a common cause of skin infections including abscesses, respiratory infections such as sinusitis, and food poisoning. Pathogenic strains often promote infections by producing virulence factors such as potent protein toxins, and the expression of a cell-surface protein that binds and inactivates antibodies. S. aureus is one of the leading pathogens for deaths associated with antimicrobial resistance and the emergence of antibiotic-resistant strains, such as methicillin-resistant S. aureus (MRSA), is a worldwide problem in clinical medicine. Despite much research and development, no vaccine for S. aureus has been approved.

<span class="mw-page-title-main">SARS</span> Disease caused by severe acute respiratory syndrome coronavirus

Severe acute respiratory syndrome (SARS) is a viral respiratory disease of zoonotic origin caused by the virus SARS-CoV-1, the first identified strain of the SARS-related coronavirus. The first known cases occurred in November 2002, and the syndrome caused the 2002–2004 SARS outbreak. In the 2010s, Chinese scientists traced the virus through the intermediary of Asian palm civets to cave-dwelling horseshoe bats in Xiyang Yi Ethnic Township, Yunnan.

<span class="mw-page-title-main">2002–2004 SARS outbreak</span> Epidemic of severe acute respiratory syndrome originating in China

The 2002–2004 outbreak of SARS, caused by severe acute respiratory syndrome coronavirus, infected over 8,000 people from 30 countries and territories, and resulted in at least 774 deaths worldwide.

<span class="mw-page-title-main">Emerging infectious disease</span> Infectious disease of emerging pathogen, often novel in its outbreak range or transmission mode

An emerging infectious disease (EID) is an infectious disease whose incidence has increased recently, and could increase in the near future. The minority that are capable of developing efficient transmission between humans can become major public and global concerns as potential causes of epidemics or pandemics. Their many impacts can be economic and societal, as well as clinical. EIDs have been increasing steadily since at least 1940.

<span class="mw-page-title-main">Staphylococcal infection</span> Medical condition

A staphylococcal infection or staph infection is an infection caused by members of the Staphylococcus genus of bacteria.

<span class="mw-page-title-main">Isolation (health care)</span> Measure taken to prevent contagious diseases from being spread

In health care facilities, isolation represents one of several measures that can be taken to implement in infection control: the prevention of communicable diseases from being transmitted from a patient to other patients, health care workers, and visitors, or from outsiders to a particular patient. Various forms of isolation exist, in some of which contact procedures are modified, and others in which the patient is kept away from all other people. In a system devised, and periodically revised, by the U.S. Centers for Disease Control and Prevention (CDC), various levels of patient isolation comprise application of one or more formally described "precaution".

<span class="mw-page-title-main">W. Ian Lipkin</span> Professor, microbiologist, epidemiologist

Walter Ian Lipkin is the John Snow Professor of Epidemiology at the Mailman School of Public Health at Columbia University and a professor of Neurology and Pathology at the College of Physicians and Surgeons at Columbia University. He is also director of the Center for Infection and Immunity, an academic laboratory for microbe hunting in acute and chronic diseases. Lipkin is internationally recognized for his work with West Nile virus, SARS and COVID-19.

<span class="mw-page-title-main">Mel Krajden</span>

Mel Krajden is a physician and professor of Pathology and Laboratory Medicine at the University of British Columbia in Vancouver, British Columbia, Canada. He is the medical director of the BCCDC Public Health Laboratory. Dr. Krajden obtained his BSc, MD, and FRCPC at McGill University, followed by a fellowship in Infectious Diseases at Stanford University. He is also the medical director of the Public Health Laboratory at the British Columbia Centre for Disease Control. His research focuses on the prevention and care of hepatitis, human papillomavirus, and human immunodeficiency virus.

Novel coronavirus (nCoV) is a provisional name given to coronaviruses of medical significance before a permanent name is decided upon. Although coronaviruses are endemic in humans and infections normally mild, such as the common cold, cross-species transmission has produced some unusually virulent strains which can cause viral pneumonia and in serious cases even acute respiratory distress syndrome and death.

<span class="mw-page-title-main">Superspreading event</span> Event in which 3 or more people attend and an infectious disease is spread much more than usual

A superspreading event (SSEV) is an event in which an infectious disease is spread much more than usual, while an unusually contagious organism infected with a disease is known as a superspreader. In the context of a human-borne illness, a superspreader is an individual who is more likely to infect others, compared with a typical infected person. Such superspreaders are of particular concern in epidemiology.

Sharon Jayne Peacock is a British microbiologist who is Professor of Public Health and Microbiology in the Department of Medicine at the University of Cambridge. Peacock also sits on Cambridge University Council.

<span class="mw-page-title-main">COVID-19</span> Contagious disease caused by SARS-CoV-2

Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the virus SARS-CoV-2. The first known case was identified in Wuhan, China, in December 2019. The disease quickly spread worldwide, resulting in the COVID-19 pandemic.

<span class="mw-page-title-main">COVID-19 surveillance</span> Measures to monitor the spread of the respiratory disease

COVID-19 surveillance involves monitoring the spread of the coronavirus disease in order to establish the patterns of disease progression. The World Health Organization (WHO) recommends active surveillance, with focus of case finding, testing and contact tracing in all transmission scenarios. COVID-19 surveillance is expected to monitor epidemiological trends, rapidly detect new cases, and based on this information, provide epidemiological information to conduct risk assessment and guide disease preparedness.

Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.

Samira Mubareka is a Canadian microbiologist who is a clinical scientist at the Sunnybrook Health Sciences Centre in Toronto, Ontario. Her research considers the influenza virus, viral transmission and aerobiology. During the COVID-19 pandemic Mubareka isolated the genome of Severe acute respiratory syndrome coronavirus 2 in an effort to improve detection and diagnostics. She served as a member of the Ontario COVID-19 Science Advisory Table.

<span class="mw-page-title-main">Timeline of the COVID-19 pandemic in 2019</span> Sequence of major events in a virus pandemic

This article documents the chronology and epidemiology of SARS-CoV-2 in 2019, the virus that causes coronavirus disease 2019 (COVID-19) and is responsible for the COVID-19 pandemic. The first human cases of COVID-19 known to have been identified were in Wuhan, Hubei, China, in December 2019. It marked the beginning of the 2019–2020 COVID-19 outbreak in mainland China.

<span class="mw-page-title-main">Andrea Ammon</span> German physician

Andrea Ammon is a German physician and the current director of the European Centre for Disease Prevention and Control (ECDC), a European Union (EU) agency strengthening Europe's defence against infectious disease. She advised the German government on the SARS and Influenza A virus subtype H2N2 outbreaks.

<span class="mw-page-title-main">Paul Tambyah</span> Singaporean doctor, professor and politician

Paul Anantharajah Tambyah, is a Singaporean doctor and professor of infectious diseases, a politician, and a writer. He is President of the Asia Pacific Society of Clinical Microbiology and Infection and also President of the International Society for Infectious Diseases. He is also the Chairman of the Singapore Democratic Party, a position he has held since September 2017.

<span class="mw-page-title-main">Yee-Sin Leo</span> Singaporean physician

Yee-Sin Leo is a Singaporean physician. Leo is the executive director of the National Centre for Infectious Diseases and researches emerging infectious diseases. She has been in charge of Singapore's response to several outbreaks, including Nipah, SARS and COVID-19. In 2020, she was selected as one of the BBC's top 100 Women.

An occupational infectious disease is an infectious disease that is contracted at the workplace. Biological hazards (biohazards) include infectious microorganisms such as viruses, bacteria and toxins produced by those organisms such as anthrax.

References

  1. "Find A Doctor - NUH | National University Hospital". www.nuh.com.sg. Retrieved 2020-05-14.
  2. "The National Infection Prevention and Control Guidelines For Acute Healthcare Facilities 2017" (PDF). Ministry of Health, Singapore. Retrieved 14 May 2020.
  3. "Dale Fisher on Google Scholar". Google Scholar. Retrieved 15 December 2023.
  4. "WHO | WHO Director-General's opening remarks at the 31st GOARN Steering Committee Meeting, Global outbreak alert and response network (GOARN) – 14 June 2022". WHO. Retrieved 2023-12-01.
  5. "UWCSEA alumnus is infectious disease specialist at the National University of Singapore" (PDF). UWCSEA Alumni. Archived from the original (PDF) on 17 April 2020. Retrieved 13 May 2020.
  6. "Meningitis Hospitalizes Jerry Lewis". AP NEWS. Retrieved 2020-05-14.
  7. "'Bush' doctor". Northern Territory News. September 1999.
  8. Fisher, D.; Burrow, J. (2003). "The Bali bombings of 12 October, 2002: lessons in disaster management for physicians". Internal Medicine Journal. 33 (3): 125–126. doi: 10.1046/j.1445-5994.2003.00371.x . ISSN   1445-5994. PMID   12603586.
  9. Fisher, Dale A.; Chew, Madeleine H. L.; Lim, Yean-Teng; Tambyah, Paul A. (2003-06-02). "Preventing local transmission of SARS: lessons from Singapore". The Medical Journal of Australia. 178 (11): 555–558. doi:10.5694/j.1326-5377.2003.tb05358.x. PMC   7168499 . PMID   12765503.
  10. Singh, Kamaljit; Hsu, Li-Yang; Villacian, Jorge S.; Habib, Abdulrazaq; Fisher, Dale; Tambyah, Paul A. (2003). "Severe Acute Respiratory Syndrome: Lessons from Singapore". Emerging Infectious Diseases. 9 (10): 1294–8. doi:10.3201/eid0910.030388. PMC   3033073 . PMID   14609466.
  11. Fisher, Dale A.; Lim, Tow-Keang; Lim, Yean-Teng; Singh, Kamaljit S.; Tambyah, Paul A. (2003-05-17). "Atypical presentations of SARS". The Lancet. 361 (9370): 1740. doi:10.1016/S0140-6736(03)13336-3. ISSN   0140-6736. PMID   12767755. S2CID   26668557.
  12. Lynette Pereira; Dale Fisher (October 2008). "Methicillin Resistant Staphylococcus aureus Control in Singapore - Moving Forward" (PDF). ANNALS Academy of Medicine. 37: 891–896.
  13. Fisher, D.; Tambyah, P. A.; Lin, R. T. P.; Jureen, R.; Cook, A. R.; Lim, A.; Ong, B.; Balm, M.; Ng, T. M.; Hsu, L. Y. (2013-10-01). "Sustained meticillin-resistant Staphylococcus aureus control in a hyper-endemic tertiary acute care hospital with infrastructure challenges in Singapore". Journal of Hospital Infection. 85 (2): 141–148. doi:10.1016/j.jhin.2013.07.005. ISSN   0195-6701. PMC   7114850 . PMID   24011440.
  14. Khalik, Salma (25 July 2013). "NUH team saves patients from superbug". The Straits Times . Retrieved 14 May 2020.
  15. "Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)" (PDF). World Health Organization . Retrieved 14 May 2020.
  16. Fisher, Dale; Heymann, David (2020-02-28). "Q&A: The novel coronavirus outbreak causing COVID-19". BMC Medicine. 18 (1): 57. doi: 10.1186/s12916-020-01533-w . ISSN   1741-7015. PMC   7047369 . PMID   32106852.
  17. Griffiths, James (19 April 2020). "Singapore had a model coronavirus response, then cases spiked. What happened?". CNN. Retrieved 2020-05-14.
  18. 1 2 "Coronavirus containment is not futile, it has to be contained: Infectious diseases professor in Singapore". CNBC. 2020-03-23. Retrieved 2020-05-14.
  19. Jones, Anna (2020-04-10). "Should world worry about Singapore's virus surge?". BBC News. Retrieved 2020-05-14.
  20. "Professor analyses 'countries that have successfully contained' the deadly coronavirus". Sky News Australia. 18 March 2020. Retrieved 2020-05-14.
  21. Fisher, Dale (18 March 2020). "Why Singapore's coronavirus response worked – and what we can all learn". The Conversation. Retrieved 2020-05-14.